Keywords: large, hba1c, reduction, novo, liraglutide, danish, insulin

Large HbA1c reduction with Novo's liraglutide

Article | 24 September 2007

Print This

Danish insulin giant Novo Nordisk says that clinical results from the fourth of five Phase III studies with its once-daily ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in